Calcium citrate and vitamin D in the treatment of osteoporosis

Clinical Drug Investigation

Volumn 31, Issue 5, 2011, Pages 285-298

  Quesada Gómez, José Manuel ^a   Blanch Rubió, Josep ^b   Díaz Curiel, Manuel ^c,d   Díez Pérez, Adolfo ^e  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Calcium citrate; Colecalciferol; Osteoporosis; prevention; therapeutic use; treatment

Indexed keywords

CALCIUM CARBONATE; CALCIUM PHOSPHATE; CALCIUM SALT; CITRATE CALCIUM; OMEPRAZOLE; STRONTIUM RANELATE; VITAMIN D;

ABDOMINAL DISTENSION; AREA UNDER THE CURVE; CALCIUM ABSORPTION; CELL TRANSPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG SAFETY; DRUG TOLERABILITY; FLATULENCE; HIP FRACTURE; HUMAN; IONIZATION; NEPHROLITHIASIS; OSTEOPOROSIS; PATIENT COMPLIANCE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; REVIEW; STOMACH SECRETION; STONE FORMATION; VITAMIN SUPPLEMENTATION;

EID: 79953809987     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11584940-000000000-00000     Document Type: Review

References (101)

1. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int 2002 Feb; 70 (2): 70-3 (Pubitemid 36935452)
2. Consensus conference: osteoporosis. JAMA 1984 Aug 10; 252 (6): 799-802
3. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001 Feb 14; 285 (6): 785-95
4. Opinion of the Scientific Committee on Food on the tolerable upper intake level of calcium. 2003 [online]. Available from http://ec.europa.eu/food/fs/sc/ scf/out194-en.pdf [Accessed 2009 Dec 8]
5. Dietary guidelines for Americans. 2009 [online]. Available from URL: http://www.health.gov/dietaryguidelines [Accessed 2005 Mar 23]
6. Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data 1994 Nov 14; (258): 1-28
7. The Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, National Academy of Sciences. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press, 1997
8. US. Department of Health & Human Services. Bone health and osteoporosis: a report of the Surgeon General. 2004 [online]. Available from URL: http://www.surgeongeneral. gov/library/bonehealth/content.html [Accessed 2009 Dec 15]
9. Optimal calcium intake. NIH Consensus Statement 1994 Jun 6-8; 12 (4): 1-31
10. Amorim Cruz JA, Moreiras O, Brzozowska A. Longitudinal changes in the intake of vitamins and minerals of elderly Europeans. SENECA investigators. Eur J Clin Nutr 1996 Jul; 50 Suppl. 2: S77-85 (Pubitemid 26283328)
11. Gonzalez Bonillo J, Murillo Ramos JJ, Sanz Perez B, et al. Intake of calcium and vitamin D by the Pyrenean popu-lation. Nutr Hosp 1997 Nov-Dec; 12 (6): 318-20
12. Navarro MC, Lanez P, Saavedra P, et al. Consumption of calcium in the diet, bone mass and standards of living in post menopausal women with and without osteoporosis. Rev Esp Nutr Communitaria 1997; 3: 15-324
13. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004 Dec; 80 (6 Suppl.): 1689S-96S
14. Quesada JM, Mata JM, Cortes X, et al. Low calcium intake and insufficient serum vitamin D status in treated and non treated postmenopausal osteoporoticwomen in Spain: the PREVICAD study [abstract]. Osteoporos Int 2008; 19 Suppl. 1: S29-207
15. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004 Apr 28; 291 (16): 1999-2006 (Pubitemid 38544282)
16. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006 Feb 27; 166 (4): 424-30
17. Richy F, Schacht E, Bruyere O, et al. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-anal-ysis. Calcif Tissue Int 2005 Mar; 76 (3): 176-86 (Pubitemid 41557146)
18. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003 Mar 1; 326 (7387): 469-72 (Pubitemid 36269626)
19. Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009; (2): CD000227
20. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992 Dec 3; 327 (23): 1637-42
21. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: con-firmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002 Mar; 13 (3): 257-64 (Pubitemid 34408194)
22. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N EnglJ Med 1997 Sep 4; 337 (10): 670-6 (Pubitemid 27375473)
23. Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. En-docr Rev 2002 Aug; 23 (4): 560-9 (Pubitemid 34925650)
24. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007 Aug 25; 370 (9588): 657-66 (Pubitemid 47285316)
25. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanal-ysis of randomized controlled trials. J Clin Endocrinol Metab 2007 Apr; 92 (4): 1415-23 (Pubitemid 46556419)
26. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-anal-ysis of randomized controlled trials. JAMA 2005 May 11; 293 (18): 2257-64 (Pubitemid 40629192)
27. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006 Feb 16; 354 (7): 669-83 (Pubitemid 43247138)
28. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996 Feb 15; 124 (4): 400-6 (Pubitemid 26065071)
29. Meyer HE, Smedshaug GB, Kvaavik E, et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002 Apr; 17 (4): 709-15 (Pubitemid 34246647)
30. Osteoporosis: clinical guidelines for prevention and treatment: working party report. 2001 [online]. Available from update.htm [Accessed 2009 Dec 15]
31. Grupo de Trabajo de la Sociedad Espanola de Investigaciones Oseas y Metabolismo Mineral (SEIOMM): Postmenopausal osteoporosis: clinical practice guide. Rev Clin Esp 2003 Oct; 203 (10): 496-506
32. Brown JP, Fortier M, Frame H, et al. Canadian consensus conference on osteoporosis, 2006 update. J Obstet Gynaecol Can 2006 Feb; 28 (2 Suppl. 1): S95-112
33. Storm T, Thamsborg G, Steiniche T, et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteopor-osis. N Engl J Med 1990 May 3; 322 (18): 1265-71 (Pubitemid 20152489)
34. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996 Dec 7; 348 (9041): 1535-41 (Pubitemid 26411651)
35. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998 Dec 23-30; 280 (24): 2077-82 (Pubitemid 29014065)
36. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a random-ized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999 Oct 13; 282 (14): 1344-52 (Pubitemid 29483192)
37. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000; 11 (1): 83-91 (Pubitemid 30099515)
38. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001 Feb 1; 344 (5): 333-40 (Pubitemid 32107641)
39. Chesnut IC, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on frac-ture risk in postmenopausal osteoporosis. J Bone Miner Res 2004 Aug; 19 (8): 1241-9 (Pubitemid 41094364)
40. Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteopor-osis. N Engl J Med 2007 May 3; 356 (18): 1809-22 (Pubitemid 46698462)
41. Chesnut 3rd CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000 Sep; 109 (4): 267-76
42. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Ralox-ifene Evaluation (MORE) Investigators. JAMA 1999 Aug 18; 282 (7): 637-45 (Pubitemid 29384151)
43. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N EnglJ Med 2004 Jan 29; 350 (5): 459-68 (Pubitemid 38133766)
44. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005 May; 90 (5): 2816-22 (Pubitemid 40686329)
45. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mi-neral density in postmenopausal women with osteopor-osis. N Engl J Med 2001 May 10; 344 (19): 1434-41 (Pubitemid 32402100)
46. Greenspan SL, Bone HG, Ettinger MP, et al. Effect of recombinant human parathyroid hormone (1-84) on ver-tebral fracture and bone mineral density in postmeno-pausal women with osteoporosis: a randomized trial. Ann Intern Med 2007 Mar 6; 146 (5): 326-39 (Pubitemid 351650593)
47. Heaney RP, Magowan S, Zhou X, et al. Prevalence of low calcium intake in postmenopasual osteoporotic women: the need for supplementation [abstract no. M276]. 27th meeting of the American Society for Bone Mineral Research; 2005 Sep 23-27; Nashville (TN)
48. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005 Jun; 90 (6): 3215-24 (Pubitemid 41014278)
49. Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006 Sep; 260 (3): 245-54 (Pubitemid 44253638)
50. Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteopor-osis. Osteoporos Int 2009 Feb; 20 (2): 239-44
51. Cashman KD. Calcium intake, calcium bioavailability and bone health. Br J Nutr 2002 May; 87 Suppl. 2: S169-77 (Pubitemid 34685551)
52. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 2005 Jan; 85 (1): 373-422 (Pubitemid 40171261)
53. Perez AV, Picotto G, Carpentieri AR, et al. Minireview on regulation of intestinal calcium absorption: emphasis on molecular mechanisms of transcellular pathway. Digestion 2008; 77 (1): 22-34 (Pubitemid 351552975)
54. Wasserman RH. Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 2004 Nov; 134 (11): 3137-9 (Pubitemid 39470097)
55. Nordin BEC, Need AG. The relation between serum calcidiol and calcitriol. BoneKEy-Osteovision 2005; 2: 7-16
56. Ivanovich P, Fellows H, Rich C The absorption of calcium carbonate. Ann Intern Med 1967 May; 66 (5): 917-23
57. Bo-Linn GW, Davis GR, Buddrus DJ, et al. An evaluation of the importance of gastric acid secretion in the absorp-tion of dietary calcium. J Clin Invest 1984 Mar; 73 (3): 640-7 (Pubitemid 14156843)
58. Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985 Jul 11; 313 (2): 70-3 (Pubitemid 15068699)
59. Hansen C, Werner E, Erbes HJ, et al. Intestinal calcium absorption from different calcium preparations: influence of anion and solubility. Osteoporos Int 1996; 6 (5): 386-93 (Pubitemid 26355897)
60. Harvey JA, Kenny P, Poindexter J, et al. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. J Am Coll Nutr 1990 Dec; 9 (6): 583-7
61. Harvey JA, Zobitz MM, Pak CY. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988 Jun; 3 (3): 253-8
62. Hurwitz A, Brady DA, Schaal SE, et al. Gastric acidity in older adults. JAMA 1997 Aug 27; 278 (8): 659-62 (Pubitemid 27373840)
63. Krasinski SD, Russell RM, Samloff IM, et al. Fundic atrophic gastritis in an elderly population: effect on hemoglobin and several serum nutritional indicators. J Am Geriatr Soc 1986 Nov; 34(11): 800-6 (Pubitemid 17178748)
64. Newton JL. Effect of age-related changes in gastric physiology on tolerability of medications for older people. Drugs Aging 2005; 22 (8): 655-61 (Pubitemid 41138978)
65. Ensrud KE, Duong T, Cauley JA, et al. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Intern Med 2000 Mar 7; 132 (5): 345-53 (Pubitemid 30127772)
66. O'Connell MB, Madden DM, Murray AM, et al. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 2005 Jul; 118 (7): 778-81 (Pubitemid 40897665)
67. Targownik LE, Lix LM, Metge CJ, et al. Use of proton pump inhibitors and risk of osteoporosis-related frac-tures. CMAJ 2008; 179: 306-7
68. Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 2006 Aug; 79 (2): 76-83 (Pubitemid 44306164)
69. Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006 Dec 27; 296 (24): 2947-53 (Pubitemid 46021498)
70. Sheikh MS, Ramirez A, Emmett M, et al. Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium. J Clin Invest 1988 Jan; 81 (1): 126-32 (Pubitemid 18092243)
71. Heller HJ, Greer LG, Haynes SD, et al. Pharmacokinetic and pharmacodynamic comparison of two calcium sup-plements in postmenopausal women. J Clin Pharmacol 2000 Nov; 40 (11): 1237-44
72. Heaney RP, Dowell MS, Barger-Lux MJ. Absorption of calcium as the carbonate and citrate salts, with some ob-servations on method. Osteoporos Int 1999; 9 (1): 19-23 (Pubitemid 29086160)
73. Heaney RP, Dowell MS, Bierman J, et al. Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 2001 Jun; 20 (3): 239-46 (Pubitemid 32606171)
74. Sakhaee K, Bhuket T, Adams-Huet B, et al. Meta-analysis of calcium bioavailability: a comparison of calcium ci-trate with calcium carbonate. Am J Ther 1999 Nov; 6 (6): 313-21
75. Nicar MJ, Pak CY. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab 1985 Aug; 61 (2): 391-3 (Pubitemid 15044280)
76. Sheikh MS, Maguire JA, Emmett M, et al. Reduction of dietary phosphorus absorption by phosphorus binders: a theoretical, in vitro, and in vivo study. J Clin Invest 1989 Jan; 83 (1): 66-73 (Pubitemid 19048406)
77. Reid IR, Schooler BA, Hannan SF, et al. The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med 1986 Apr; 16 (2): 193-7 (Pubitemid 17184768)
78. Hunt JN, Johnson C Relation between gastric secretion of acid and urinary excretion of calcium after oral supple-ments of calcium. Dig Dis Sci 1983 May; 28 (5): 417-21 (Pubitemid 13086687)
79. Reginster JY, Denis D, Bartsch V, et al. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int 1993 Sep; 3 (5): 271-5 (Pubitemid 23252447)
80. Miller JZ, Smith DL, Flora L, et al. Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents. Am J Clin Nutr 1988 Nov; 48 (5): 1291-4
81. Smith KT, Heaney RP, Flora L, et al. Calcium absorption from a new calcium delivery system (CCM). Calcif Tissue Int 1987 Dec; 41 (6): 351-2
82. Thomas SD, Need AG, Tucker G, et al. Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women. Calcif Tissue Int 2008 Aug; 83 (2): 81-4
83. Guillemant S, Guillemant J, Duntze P. Comparison of the biochemical and hormonal acute effects of calcium salts. Osteoporos Int 1995 Jan; 5 (1): 66-7
84. Terris S. Calcium plus vitamin D and the risk of fractures [letter]. N Engl J Med 2006 May 25; 354 (21): 2285-7; author reply 2287
85. Moyad MA. Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes. Urol Nurs 2003 Aug; 23 (4): 310-3
86. Williams CP, Child DF, Hudson PR, et al. Why oral calcium supplements may reduce renal stone disease: re-portofaclinicalpilot study. J Clin Pathol 2001 Jan; 54(1): 54-62 (Pubitemid 32048296)
87. Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for pre-vention of osteoporosis. Am J Clin Nutr 1994 Oct; 60 (4): 592-6 (Pubitemid 24313007)
88. Heaney RP. Nutrition and risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego (CA): Academic Press, 1996: 483-509
89. Sakhaee K, Baker S, Zerwekh J, et al. Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects. J Urol 1994 Aug; 152 (2 Pt 1): 324-7 (Pubitemid 24221211)
90. Sakhaee K, Poindexter JR, Griffith CS, et al. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol 2004 Sep; 172 (3): 958-61 (Pubitemid 39096433)
91. Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption. Am J Clin Nutr 1991 Jan; 53 (1): 106-11 (Pubitemid 21917617)
92. Hallberg L, Brune M, Erlandsson M, et al. Calcium: effect of different amounts on nonhemeand heme-iron absorp-tion in humans. Am J Clin Nutr 1991 Jan; 53 (1): 112-9 (Pubitemid 21917618)
93. Preziosi P, Hercberg S, Galan P, et al. Iron status of a healthy French population: factors determining bio-chemicalmarkers. Ann Nutr Metab 1994; 38 (4): 192-202 (Pubitemid 24322235)
94. Somer E. Minerals. In: The essential guide to vitamins and minerals. New York (NY): Harper Perennial, 1995: 89-94
95. Rossini M, Bianchi G, Di Munno O, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006; 17 (6): 914-21 (Pubitemid 43781506)
96. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised place-bo-controlled trial. Lancet 2005 May 7-13; 365 (9471): 1621-8 (Pubitemid 40693411)
97. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with chole-calciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005 Apr 30; 330 (7498): 1003. doi:10.1136/bmj.330.7498.1003
98. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 Aug 4; 353 (5): 487-97 (Pubitemid 41127293)
99. Cooper A, Drake J, Brankin E. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Pract 2006 Aug; 60 (8): 896-905 (Pubitemid 44082279)
100. Cramer JA, Amonkar MM, Hebborn A, et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005 Sep; 21 (9): 1453-60 (Pubitemid 41368578)
101. a Reunion del Grupo de Trabajo de OP de la SEMI; 2008